(Q37604884)

21 August 2017

1 reference

title

Selective iNOS inhibition for the treatment of sepsis-induced acute kidney injury (English)

1 reference

21 August 2017

0 references

Suzanne Heemskerk

1

1 reference

21 August 2017

Rosalinde Masereeuw

series ordinal

2

1 reference

21 August 2017

Frans G M Russel

series ordinal

3

1 reference

21 August 2017

Peter Pickkers

series ordinal

4

1 reference

21 August 2017

language of work or name

English

0 references

publication date

29 September 2009

1 reference

Nature Reviews Nephrology

21 August 2017

published in

1 reference

21 August 2017

volume

5

1 reference

21 August 2017

issue

11

1 reference

21 August 2017

page(s)

629-640

1 reference

https://scigraph.springernature.com/pub.10.1038/nrneph.2009.155

21 August 2017

exact match

0 references

cites work

Nitric oxide and septic shock

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Cardiovascular and renal control in NOS-deficient mouse models

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Alkaline phosphatase treatment improves renal function in severe sepsis or septic shock patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Renal effects of nitric oxide in endotoxemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Peritubular capillary loss after mouse acute nephrotoxicity correlates with down-regulation of vascular endothelial growth factor-A and hypoxia-inducible factor-1 alpha.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

New insight in LPS antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Attenuation of endotoxin-induced multiple organ dysfunction by 1-amino-2-hydroxy-guanidine, a potent inhibitor of inducible nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

L-canavanine improves organ function and tissue adenosine triphosphate levels in rodent endotoxemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Response of man to endotoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Role of Toll-like receptor 4 in endotoxin-induced acute renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

The multiple organ dysfunction syndrome caused by endotoxin in the rat: attenuation of liver dysfunction by inhibitors of nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Selective iNOS inhibition is superior to norepinephrine in the treatment of rat endotoxic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Treatment of septic shock with human monoclonal antibody HA-1A. A randomized, double-blind, placebo-controlled trial. CHESS Trial Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Efficacy and safety of the monoclonal anti-tumor necrosis factor antibody F(ab')2 fragment afelimomab in patients with severe sepsis and elevated interleukin-6 levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Effects of severity of illness on resource use by survivors and nonsurvivors of severe sepsis at intensive care unit admission.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Sepsis in European intensive care units: results of the SOAP study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Brazilian Sepsis Epidemiological Study (BASES study)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Mortality after acute renal failure: models for prognostic stratification and risk adjustment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Potential interventions in sepsis-related acute kidney injury

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Septic Acute Kidney Injury in Critically Ill Patients: Clinical Characteristics and Outcomes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Acute kidney injury in patients with sepsis: a contemporary analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Acute kidney injury in septic shock: clinical outcomes and impact of duration of hypotension prior to initiation of antimicrobial therapy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Prognostic factors in acute renal failure due to sepsis. Results of a prospective multicentre study. The French Study Group on Acute Renal Failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Pathophysiology of septic acute kidney injury: what do we really know?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Acute renal failure in patients with sepsis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Relationship between plasma levels of lipopolysaccharide (LPS) and LPS-binding protein in patients with severe sepsis and septic shock

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Lipopolysaccharide: an endotoxin or an exogenous hormone?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Studies with radioactive endotoxin. II. Correlation of physiologic effects with distribution of radioactivity in rabbits injected with radioactive sodium chromate

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Analysis of lipopolysaccharide (LPS)-binding characteristics of serum components using gel filtration of FITC-labeled LPS.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Lipopolysaccharide recognition: CD14, TLRs and the LPS-activation cluster

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Toll-like receptors TLR2 and TLR4 initiate the innate immune response of the renal tubular epithelium to bacterial products.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Molecular mechanisms involved in the pathogenesis of septic shock

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Sepsis-induced organ failure is mediated by different pathways in the kidney and liver: acute renal failure is dependent on MyD88 but not renal cell apoptosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

The immunopathogenesis of sepsis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Expression of tumor necrosis factor receptors in normal kidney and rejecting renal transplants

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Acute renal failure and sepsis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Endotoxemic renal failure in mice: Role of tumor necrosis factor independent of inducible nitric oxide synthase

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Intrarenal haemodynamics and renal dysfunction in endotoxaemia: effects of nitric oxide synthase inhibition

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Renal haemodynamic, microcirculatory, metabolic and histopathological responses to peritonitis-induced septic shock in pigs

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Low-dose dexamethasone-supplemented fluid resuscitation reverses endotoxin-induced acute renal failure and prevents cortical microvascular hypoxia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Elevated plasma concentrations of IL-6 and elevated APACHE II score predict acute kidney injury in patients with severe sepsis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Nitric oxide generation mediates lipid A-induced oxidant injury in renal proximal tubules

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

NO generation from nitrite and its role in vascular control

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Systemic NO production during (septic) shock depends on parenchymal and not on hematopoietic cells: in vivo iNOS expression pattern in (septic) shock.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Cytokine-induced expression of a nitric oxide synthase in rat renal tubule cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Upregulation of renal inducible nitric oxide synthase during human endotoxemia and sepsis is associated with proximal tubule injury.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Blocking NO synthesis: how, where and why?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

The role of nitric oxide in the regulation of glomerular haemodynamics in humans

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Neuronal nitric oxide synthase inhibition sensitizes the tubuloglomerular feedback mechanism after volume expansion

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Nitric oxide and angiotensin II. Glomerular and tubular interaction in the rat

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Inhibition of constitutive nitric oxide synthase (NOS) by nitric oxide generated by inducible NOS after lipopolysaccharide administration provokes renal dysfunction in rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Protection against lipopolysaccharide-induced endothelial dysfunction in resistance and conduit vasculature of iNOS knockout mice.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Endogenously synthesized nitric oxide prevents endotoxin-induced glomerular thrombosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Multiple pathways of peroxynitrite cytotoxicity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Alterations of mitochondrial function in sepsis and critical illness

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Simulation of the diffusion and reaction of endogenously produced nitric oxide

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Nitric oxide: a mediator in rat tubular hypoxia/reoxygenation injury

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Effect of hypoxia on proximal tubules isolated from nitric oxide synthase knockout mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Tyrosine nitration: localisation, quantification, consequences for protein function and signal transduction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Evidence for the role of reactive nitrogen species in polymicrobial sepsis-induced renal peritubular capillary dysfunction and tubular injury

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Classification of spatiotemporal hemodynamics from brain perfusion MR images using expectation-maximization estimation with finite mixture of multivariate gaussian distributions.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

The sources of oxidative stress in the vessel wall

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Endothelial injury and dysfunction: role in the extension phase of acute renal failure.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Disruption of renal peritubular blood flow in lipopolysaccharide-induced renal failure: role of nitric oxide and caspases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

A role for nitric oxide-mediated peroxynitrite formation in a model of endotoxin-induced shock.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Nitric oxide differentially regulates renal ATP-binding cassette transporters during endotoxemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Role of nitric oxide in lipopolysaccharide-induced oxidant stress in the rat kidney.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Clinical evidence of peroxynitrite formation in chronic renal failure patients with septic shock

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Nitric oxide (NO) production correlates with renal insufficiency and multiple organ dysfunction syndrome in severe sepsis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Cytokines, nitrite/nitrate, soluble tumor necrosis factor receptors, and procalcitonin concentrations: comparisons in patients with septic shock, cardiogenic shock, and bacterial pneumonia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Nitrogen oxide levels in patients after trauma and during sepsis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Therapeutic strategies targeting the LPS signaling and cytokines

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Neutralization of tumor necrosis factor in preclinical models of sepsis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Low-dose dexamethasone ameliorates circulatory failure and renal dysfunction in conscious rats with endotoxemia.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Ethyl pyruvate decreases sepsis-induced acute renal failure and multiple organ damage in aged mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

N-Allylsecoboldine as a novel agent prevents acute renal failure during endotoxemia.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Effects of a membrane-permeable radical scavenger, Tempol, on intraperitoneal sepsis-induced organ injury in rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Inhibition of inducible nitric oxide synthase reduces lipopolysaccharide-induced renal injury in the rat.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Selective pharmacological inhibition of distinct nitric oxide synthase isoforms

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Vascular hyporeactivity to vasoconstrictor agents and hemodynamic decompensation in hemorrhagic shock is mediated by nitric oxide

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Randomized trial of an inhibitor of formation of advanced glycation end products in diabetic nephropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Mercaptoethylguanidine and guanidine inhibitors of nitric-oxide synthase react with peroxynitrite and protect against peroxynitrite-induced oxidative damage.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

The inhibitory potency and selectivity of arginine substrate site nitric-oxide synthase inhibitors is solely determined by their affinity toward the different isoenzymes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Mechanistic studies with potent and selective inducible nitric-oxide synthase dimerization inhibitors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Selective inducible nitric oxide synthase inhibition during long-term hyperdynamic porcine bacteremia.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Selective inducible nitric oxide synthase inhibition attenuates organ dysfunction and elevated endothelin levels in LPS-induced DIC model rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Effect of methylguanidine in a model of septic shock induced by LPS.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Prevention and treatment of acute renal failure in sepsis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Early goal-directed therapy in the treatment of severe sepsis and septic shock

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Intensive insulin therapy in critically ill patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Tight blood glucose control is renoprotective in critically ill patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

The effects of ibuprofen on the physiology and survival of patients with sepsis. The Ibuprofen in Sepsis Study Group

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Use of corticosteroid therapy in patients with sepsis and septic shock: an evidence-based review

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Glucocorticoids in the treatment of severe sepsis and septic shock

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Hydrocortisone therapy for patients with septic shock

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Risks and benefits of activated protein C treatment for severe sepsis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Efficacy and safety of recombinant human activated protein C for severe sepsis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Safety of drotrecogin alfa (activated) in severe sepsis: data from adult clinical trials and observational studies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Brief report: shock and multiple-organ dysfunction after self-administration of Salmonella endotoxin.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Association between protective efficacy of anti-lipopolysaccharide (LPS) antibodies and suppression of LPS-induced tumor necrosis factor alpha and interleukin 6. Comparison of O side chain-specific antibodies with core LPS antibodies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Effect of the antiendotoxic agent, taurolidine, in the treatment of sepsis syndrome: a placebo-controlled, double-blind trial.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Assessment of ability of murine and human anti-lipid A monoclonal antibodies to bind and neutralize lipopolysaccharide

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

A rationale for the prophylactic use of monophosphoryl lipid A in sepsis and septic shock

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Proinflammatory and anti-inflammatory cytokines as mediators in the pathogenesis of septic shock

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Cytokine Cascade in Sepsis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Anti-tumor necrosis factor therapy in sepsis: update on clinical trials and lessons learned

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock. NORASEPT II Study Group

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

INTERSEPT: an international, multicenter, placebo-controlled trial of monoclonal antibody to human tumor necrosis factor-alpha in patients with sepsis. International Sepsis Trial Study Group.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Nitric oxide scavengers in the treatment of shock associated with systemic inflammatory response syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Discovery of novel and potent small-molecule inhibitors of NO and cytokine production as antisepsis agents: synthesis and biological activity of alkyl 6-(N-substituted sulfamoyl)cyclohex-1-ene-1-carboxylate

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Multicenter, randomized, placebo-controlled study of the nitric oxide scavenger pyridoxalated hemoglobin polyoxyethylene in distributive shock

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

The selective guanylate cyclase inhibitor ODQ reduces multiple organ injury in rodent models of Gram-positive and Gram-negative shock

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Methylene blue inhibits hypoxic cerebral vasodilation in awake sheep

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Inhibition of nitric oxide synthesis by methylene blue.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Short-term beneficial effects of methylene blue on kidney damage in septic shock patients.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Handling of asymmetrical dimethylarginine and symmetrical dimethylarginine by the rat kidney under basal conditions and during endotoxaemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Expression of NG,NG-dimethylarginine dimethylaminohydrolase and protein arginine N-methyltransferase isoforms in diabetic rat kidney: effects of angiotensin II receptor blockers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Septic shock is correlated with asymmetrical dimethyl arginine levels, which may be influenced by a polymorphism in the dimethylarginine dimethylaminohydrolase II gene: a prospective observational study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Effects of a nitric oxide synthesis inhibitor on renal sodium handling and diluting capacity in humans

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Effects of a nitric oxide synthase inhibitor in humans with septic shock

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

A new approach in the treatment of hypotension in human septic shock by NG-monomethyl-L-arginine, an inhibitor of the nitric oxide synthetase.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Aminoguanidine: a drug proposed for prophylaxis in diabetes inhibits catalase and generates hydrogen peroxide in vitro

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Effect of a novel inducible nitric oxide synthase inhibitor, FR260330, in prevention of renal ischemia/reperfusion injury in vervet monkeys

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

GW274150, a potent and highly selective inhibitor of iNOS, reduces experimental renal ischemia/reperfusion injury

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Discovery of a series of aminopiperidines as novel iNOS inhibitors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Poly(ADP-ribose) polymerase: a new therapeutic target?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Intravenously administered short interfering RNA accumulates in the kidney and selectively suppresses gene function in renal proximal tubules.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Nitric oxide synthase inhibition during experimental sepsis improves renal excretory function in the presence of chronically increased atrial natriuretic peptide

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

S-Methylisothiourea sulfate improves renal, but not hepatic dysfunction in canine endotoxic shock model

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Beneficial effects and improved survival in rodent models of septic shock with S-methylisothiourea sulfate, a potent and selective inhibitor of inducible nitric oxide synthase

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Comparative effects of vasopressin, norepinephrine, and L-canavanine, a selective inhibitor of inducible nitric oxide synthase, in endotoxic shock

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

A selective inhibitor for inducible nitric oxide synthase improves hypotension and lactic acidosis in canine endotoxic shock

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Comparison of the effects of aminoguanidine and N omega-nitro-L-arginine methyl ester on the multiple organ dysfunction caused by endotoxaemia in the rat.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Treatment of gram-negative bacteremia and shock with human antiserum to a mutant Escherichia coli

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Treatment of Gram-Negative Septic Shock with Human IgG Antibody to Escherichia coli J5: A Prospective, Double-Blind, Randomized Trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Recombinant bactericidal/permeability-increasing protein (rBPI21) as adjunctive treatment for children with severe meningococcal sepsis: a randomised trial. rBPI21 Meningococcal Sepsis Study Group

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. TNF-alpha MAb Sepsis Study Group.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Infusion of methylene blue in human septic shock: a pilot, randomized, controlled study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Use of methylene blue in patients with refractory septic shock: impact on hemodynamics and gas exchange.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.155

Nitrotyrosine formation with endotoxin-induced kidney injury detected by immunohistochemistry

31 March 2020

1 reference

12 December 2020

Biosynthesis and homeostatic roles of nitric oxide in the normal kidney

1 reference

12 December 2020

Severe sepsis and septic shock: review of the literature and emergency department management guidelines.

1 reference

12 December 2020

Selective inhibition of the activity of inducible nitric oxide synthase prevents the circulatory failure, but not the organ injury/dysfunction, caused by endotoxin

1 reference

12 December 2020

E5 murine monoclonal antiendotoxin antibody in gram-negative sepsis: a randomized controlled trial. E5 Study Investigators

1 reference

12 December 2020

Endotoxin-induced acute renal failure in rats: effects of L-arginine and nitric oxide synthase inhibition on renal function

1 reference

12 December 2020

Methylene blue inhibits nitrovasodilator- and endothelium-derived relaxing factor-induced cyclic GMP accumulation in cultured pulmonary arterial smooth muscle cells via generation of superoxide anion

1 reference

12 December 2020

A second large controlled clinical study of E5, a monoclonal antibody to endotoxin: results of a prospective, multicenter, randomized, controlled trial. The E5 Sepsis Study Group

1 reference

12 December 2020

Role of nitric oxide in regulation of long-term pressure-natriuresis relationship in Dahl rats

1 reference

12 December 2020

Evidence of increased nitric oxide production in patients with the sepsis syndrome

1 reference

12 December 2020

Potent and selective inhibition of human nitric oxide synthases. Inhibition by non-amino acid isothioureas

1 reference

12 December 2020

Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group

1 reference

12 December 2020

Score-based immunoglobulin G therapy of patients with sepsis: the SBITS study

1 reference

12 December 2020

Inhibition of nitric oxide synthesis attenuates pressure-induced natriuretic responses in anesthetized dogs.

1 reference

12 December 2020

A controlled clinical trial of E5 murine monoclonal IgM antibody to endotoxin in the treatment of gram-negative sepsis. The XOMA Sepsis Study Group

1 reference

12 December 2020

Monoclonal antibody to tumor necrosis factor--alpha prevents lethal endotoxin sepsis in adult rhesus monkeys

1 reference

12 December 2020

Toxic effects of dimethylthiourea in rats

1 reference

12 December 2020

Antisense oligodeoxynucleotides to inducible NO synthase rescue epithelial cells from oxidative stress injury

1 reference

12 December 2020

Physiological role of nitric oxide in regulation of renal function in humans

1 reference

12 December 2020

In situ hybridization localization of mRNA encoding inducible nitric oxide synthase in rat kidney

1 reference

12 December 2020

Effects of aminoguanidine in different dosages on renal function in endotoxin induced rabbits shock model

1 reference

12 December 2020

A physiologic function for alkaline phosphatase: endotoxin detoxification.

1 reference

12 December 2020

Nitric oxide, sepsis, and the kidney.

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRNEPH.2009.155

1 reference

21 August 2017

1 reference